N
NPCE
Neuropace Inc
14.63
+0.12+0.83%Opening13:29 04/08 EDT
OPEN/PREV CLOSE15.00/14.51
TODAY RANGE14.61-15.00
VOL51.21K
MARKET CAP492.55M
52 WEEK RANGE7.56-18.98
AVG VOL (3M)205.93K
% TURNOVER0.15%
TURNOVER--
P/E (TTM)-22.3018
% RANGE2.69%
EPS(TTM)-0.6560
P/E(FORWARD)-20.6056
P/B25.81
BVPS0.5668
DIVIDEND--
P/S4.913
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP379.74M
SHARES OUTSTANDING33.67M
NEXT EARNINGS05/11-05/15
FREE FLOAT25.96M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·6d ago
NeuroPace Earnings Call Highlights Growth And AI Push
Benzinga·03/23 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·03/18 10:25
NeuroPace assumed with an Overweight at Wells Fargo
TipRanks·03/06 12:03
NeuroPace (NPCE) Receives a Buy from Wells Fargo
Reuters·03/05 21:30
NeuroPace to Present at Leerink 2026 Global Healthcare Conference
Reuters·03/04 21:44
Neuropace Chief Medical Officer Martha Morrell Disposes of Common Shares
Seeking Alpha·03/04 02:02
NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline
Reuters·03/03 22:03
NeuroPace forecasts 2026 revenue of $98 million to $100 million
Reuters·03/03 21:27
NeuroPace Q4 revenue rises
Dow Jones·03/03 21:19
*NeuroPace Sees 1Q Rev $21M-$22M >NPCE
Same Industry
Name/Symbol
Change%
Price